text:
By John Lawn Top, Cal Dining's management team: Assistant Director Mike Laux; Executive Chef/Assistant Director Chuck Davies; Marketing Coordinator Kim LaPean; Assistant Director-Operations Brian Bigelow; and Assistant Director-Purchasing Suzanne Golden. In foreground, dining services director Shawn LaPean. Views are of the newly renovated Clark Kerr dining hall, where culinary oversight is provided by Chef Ida Shen. CERTIFIED. After renovation and an environmental audit ...
Register to view this Article
Why Register for FREE?
Registering for Premium Content on Food Management will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It's FREE, easy and quick.

subset: commoncrawl


text:
Release Date: December 15th, 2006
PG|1 hr. 43 min.
Plot Summary
Eragon (Ed Speleers), a poor farm boy, lives in Alagaesia, a kingdom ruled by Galbatorix (John Malkovich), a powerful but evil monarch. One day, Eragon discovers a beautiful stone that he soon realizes is a dragon's egg. When the creature hatches, Eragon sets forth on a path that could restore the glory of his homeland's legendary Dragon Riders and perhaps overthrow Galbatorix.
Cast: Ed Speleers, Jeremy Irons, Sienna Guillory, Robert Carlyle, Djimon Hounsou, Garrett Hedlund, Rachel Weisz, Joss Stone
Director: Stefen Fangmeier
Genres: Children, Fantasy, Adventure
Distributor: 20th Century Fox


text:
So 12-7-2 on the ice at Wonderland today. Pierre-Marc Bouchard got a maintenance day, Scott Pellerin said. John Persson remained out with that lower-body issue from Friday night. Riley Wetmore's been riding the bike and is at least making progress; "hopefully he's back sooner than later."
And Johan Sundstrom was on the ice before the team this morning. He's feeling better from whatever the illness was that zonked him a week and a half before Christmas, and that was his first twirl. We'll see how things go with him the rest of the week.
Nothing yet from the AHL about Justin Johnson, who was assessed his fifth instigator of the year on Saturday. Asked him for his take on that fight with Zack Stortini, which happened during a stoppage. "It's a matter of things happening sometimes," Johnson said. "That (fight), there's probably no good reason except we're in the same spot on the rink. He's looking at me; I'm looking at him. It happens. I think there's a lot of pride in dropping the gloves. No one wants to give an inch out there." If he'd gone at it with somebody else, he could understand. "That guy (Stortini) is leading the league in penalty minutes and fighting majors," Johnson said. "It's not like it's a top-six forward or a top-four defenseman. There was a good 5-6 foot distance between us when we started throwing punches. Hopefully the league will review it and make the right call."
Nino Niederreiter and Tobias Stephan on the Swiss Olympic roster.
Dallas Eakins dropped an 8 a.m. practice on the Oilers today. Dan Marshall did it in Bridgeport on Dec. 27, 2006, if the time sounds familiar.
Can a dude in an Anders Nilsson sweater catch a puck while holding a baby? Yes. (Think Dennis McEwen went on to talk about how it used to be a beer, now it's a baby… I don't know. Forget I brought it up.)
I don't remember ever hearing this story. (Hat tip: Aaron Sims.) more on it here.
And Phil Giubileo is set to call the radio play-by-play tonight at Nassau Coliseum. (Believe you can get the stream here.) Kyle Okposo could be playing, too. They both have something going on off the ice that could change the night around. All the best to both of them.


text:
45 Reviews
Skinceuticals physical uv defense
Posted 7/20/2016 by Floting
It's no doubt an effective sunscreen! But I think it goes on too white and then your face has that white tint to it all day. So, I use this only when I'm working out. I prefer the physical fusion uv defense - the tinted one. It makes your skin so smooth, so much so that I don't wear foundation or anything after applying it (besides for a matte powder for my oily t-zone and, of course, a little blush and eyeliner)
I am going to try the matte version of the physical fusion and see how that might help my oily t-zone so i don't need to use so many blotting papers! Stay tuned...!
Hope this was helpful to some searching for that perfect product! Whichever way you go, skinceuticals is a great line and I don't think you can go wrong! (If you are not past 50, don't even consider the age Interrupter products though).
Posted 6/23/2016 by Mandi
I use this sunscreen as a moisturizer as well. I absolutely love this product. I have extremely sensitive skin and this does double duty for me. I highly recommend this if you have sensitive, oily skin and need a product to protect as well as moisturize.
Good for oily skin
Posted 6/16/2016 by Nw gurl
It doesn't leave a greasy sheen but you have to make sure to rub it all in.
Effective ingredients, but...
Posted 2/16/2016 by KIMBERLY
So far I've been very pleased with Skinceuticals products. I meant to order the Fusion version (Tinted version of this sunscreen) which I received as a sample and loved, but ordered this in error. The texture of this product is wonderful, but it left a very white cast on my entire face (and I am fairly pale). My medium foundation and bronzer combo were unable to overshadow the white color. Not so much sheer at all.
Great sunscreen
Posted 12/22/2015 by LYNN
I have been using this sheer sunscreen for two years and love they way it feels on my face. Not heavy.
Sheer and Lovely!
Posted 10/12/2015 by Ginna
I already use the tinted version of this sunscreen on my face and decided to buy the sheer for my neck because I didn't want the tint to get all over my clothes. This is a great sunscreen, goes on smoothly and cleanly and dries to a matte finish. Love it!!
Favorite sunscreen
Posted 9/25/2015 by Allison
This is the only sunscreen I will try cause I will use it for life :) it is very thin and light. Mixes well with tinted moisturizers (great with Revisions)
Light coverage
Posted 9/20/2015 by Stepho
I like how light this sunblock is. It is a little white going on but it absorbs quickly. I think this is great for oily, combo skin. Definitely comes out easily and quickly so be careful! It doesn't make me feel greasy either.
The only one that does not make my face crazy
Posted 8/31/2015 by GZE
This sunblock is the only one I have found that does not make my face shiny or break out. It does leave a white cast if you do not rub it in well.
Fantastic Sunscreen
Posted 8/17/2015 by ShawnMarie
I don't like a lot of chemicals in my skin care routine and that includes my sunscreen. I really like the ingredients and it works very well. You can look at me funny and I will break out, but not with this sunscreen. It goes on nicely and my makeup glides right on. This doesn't melt in hot weather and I've never gotten burned while using it. I highly recommend.
Great Sunscreen
Posted 8/13/2015 by Anne
I have been using this product for over a year now. I love how it feels on my skin. If I perspire, it doesn't sting my eyes. The light tint allows me to wear it without makeup and I still have an allover, even color. This is a definite must have in my make-up bag.
Posted 8/10/2015 by Absinthe
Posted 8/10/2015 by Absinthe
Finally find the best sunscreen !!! I use it everyday and it does not cause acne!!!!
Skin ceuticals sun screen
Posted 7/30/2015 by kathleen
Great Item - works well
Posted 7/30/2015 by kathleen
Great sunscreen.... It works.
Posted 7/30/2015 by kathleen
This is the best sunscreen! I started using it about a month ago, works great.
FAVE sun protection protect
Posted 7/30/2015 by Susie Q
Now this is my go-to sun protection product. I love that it is easy to apply and it absorbs so well that I do not look ghastly white from the zinc oxide! Small enough bottle to pack into my purse for reapplication through the day, too. Really happy to find this product as I have tried quite a few zinc oxide products in an effort to stay away from the other sunscreen ingredients that have given me problems.
Best facial sunscreen on the market
Posted 7/24/2015 by B.W.
I could never have imagined a sunscreen that would offer purely physical uv protection AND look great on my skin and under make up. This is my holy grail facial sunscreen product and I could never imagine using anything else.
skin ceuticals sun screen
Posted 7/16/2015 by kathleen
I have been using this since the beginning of the season and it is a wonderful product.
SkinCeuticals Sun screen
Posted 7/14/2015 by Kathy
Posted 6/2/2015 by Teri
Great matte finish.
Posted 5/15/2015 by Jenni
This product is so good. It made my face smooth and it doesn't burn my eyes.
Nice Finish
Posted 5/9/2015 by sneffie
I like the "finished look" that my face has using this sunscreen. I don't use a foundation so this is the final touch before a light blush to the cheeks. No parabens is really important to me so I am glad to see that SkinCeuticals is creating more paraben free products into the line.This sunscreen does work- less freckles when applied 365 days a year.
My old faithful
Posted 5/7/2015 by Diane
Have used this for several years now. I have oily skin and it goes on easy, there is a faint white film at first but it goes away upon absorption. Doesn't add to my oiliness at all. When I work out and sweat it doesn't burn my eyes like other sunscreens do, nor does it discolor my clothing like I have had happen to me in the past with other sunscreens.
Posted 4/26/2015 by diamonds4me
I have used several Skinceuticals sunscreens and this is one that I like very much. I use it on the really hot summer days when my skin produces more oil. It is lightweight and not greasy!
Best Sunscreen
Posted 4/23/2015 by asn
This is my favorite sunscreen after trying many, many brands ranging from cheap to expensive. Non greasy, non sticky. This is definitely worth the higher price tag!
Great sunscreen
Posted 4/16/2015 by Tonya
This is a very lightweight sunscreen. It's not greasy, however, may not be great for very dry skin.
LOVE this product
Posted 4/13/2015 by ying
LOVE this product
Great for summer
Posted 4/9/2015 by Tianfang
This is really the most sheer physical sunscreen I've ever used. It does make my face whiter but not that white ( I have medium fair skin color). I hope they could make it tinted so it would look even more natural. Another thing I like is that this product is NOT GREASY at all. Big bonus for summer.
Quality product
Posted 4/3/2015 by Farm girl
I'm liking this product so far. Stays on all day.
I wear it every day!
Posted 3/27/2015 by Big Red
Excellent sunblock that feels like makeup and doesn't smell like sunscreen. Easy to wear and flattering. Nobody knows you have it on. I recommend it highly.
No breakouts!
Posted 2/1/2015 by Jill
Love that I found a sunscreen that doesn't cause me to break-out!
Great for sensitive, intollerant skin!
Posted 1/26/2015 by GE
I have tried MANY sunblocks - All from Skinceuticals, La Roche Posey, Elta MD, Obagi. This one seems to work the best: dry finish, rubs in clear, does not cause acne or skin irritation, works under my makeup. I recommend this is you have sensitive, intolerant, oily/normal skin.
Lightweight feel
Posted 1/16/2015 by GrillQueen
This sunscreen is not chalky at all as over-the-counter face creams. It goes on smoothly and feels really good. It is not greasy and absorbs quickly. I recommend this product 100%.
Great sunscreen
Posted 11/25/2014 by Marie
This sunscreen is not oily. It lives up the title..."sheer" physical fusion. I have used it for several years and just ordered 5 bottles.
Best Sunscreen Ever for acne-prone skin
Posted 10/25/2014 by Joanna
I have suffered acne for over 10 years. It has been difficult to find a sunscreen that provides enough protection without causing break-up and goes on thin. This sunscreen is the best so far. I have used 2 bottles and ordered two extra bottles for winter break and next summer.
The sunscreen goes on smooth, light and clear with a matte finish. It provides the sheer of tinted moisturizer, which evens out skin tone. The smooth finish serves well under make-up.
Regarding on water resistant, it is very water resistant. I don't have to reapply sunscreen during normal working days.
Best sunscreen so far for acne prone skin.
Very light, goes on clear, mattifying
Posted 3/23/2013 by Kenadi
My aesthetician recommended this sunblock. I have sensitive combination congested (acne-prone) skin.---I wanted something with a physical sunblock and no parabens, fragrances and stuff like that. A little goes a long way. I put a few dabs around my face and rub it in. It goes on completely clear for me. I'm Asian with medium-light skin tone. I like how light it feels and I don't get the shiny forehead and greasy-sticky feel. I would recommend putting some moisturizer on dry spots first if you are concerned about that this accentuating dry skin. I haven't found this to be my case, but for those with really dry skin it might help. I don't have the white cast with this. I think it's all in how much you use and how well you rub it in. I've learned that less is more with physical sunscreens and it works fine. You don't need to glob on a bunch. Another technique is to layer it on if you want to feel secure that you've lathered your face with sunscreen. I think this is a great sunscreen for summer/warmer months or humid areas. So far no breakouts or irritations. My only complaint is I am not a fan of the smell. Good thing is it seems to go away after a little while.
BEST! Yay- no breakouts!!!!
Posted 11/4/2012 by Sharon
I switched to this sunscreen last year after using Anthelios for years and struggling with breakouts and the greasy feeling it always left on my skin (I need a high uva uvb sunscreen). I LOVE it. The breakouts stopped immediately, my pores cleared up and the sunscreen absorbed quickly and left my skin with an almost dewy finish to it (added bonus). I ran out of this sunscreen and briefly went back to Anthelios and the breakouts started again almost immediately. This is the only sunscreen for me!
No breakouts from this sunscreen!
Posted 7/8/2012 by MJL
I've been using this product for over a year now. I have very fair skin and really like the sheer mattifying effect of this sunscreen. Used alone or under makeup I have seen the results -- no new sunspots or color -- must be doing the trick!
Posted 4/10/2012 by Denise
For the first time ever, my skin looks flawless. I received a sample bottle of this sunscreen, and skeptically applied it. Instead of the white/heavy/slick/pore-clogging results I usually get, I dusted mineral powder over this and watched my pores vanish before my eyes. My skin stayed comfortably matte and perfect for the entire day. I am so impressed with this gem that I can see myself as a lifelong purchaser. The tint doesn't alter my powder color, just makes it invisible on the skin (my skin tone is fair to light). Wonderful product for those needing sun protection. I'm sold!
Amazing Sunscreen!!!
Posted 2/18/2011 by Sandra
Finally someone made a sunscreen with zinc that is not sticky... I dunno how anyone can say this sunscreen leaves white marks, this rubs in super quick and dries like a mattifying moisturizer. I actually couldn't believe how easily it absorbed. Considering I have tried almost every zinc sunscreen out there. If it leaves any white residue you are probably using way to much ....another reason I love this sunscreen...A little goes a long way so you get more for your money...I have oily skin with hormonal breakouts and this stuff allows me to wear sunscreen under my make up without feeling oily or sticky..its AMAZING..... Sandra
Posted 11/26/2010 by Lori M
I've tried many sunscreens. This is not greasy at all. It does not leave a white mask as long as you don't use too much. A little goes a long way. It actually makes my skin look nicer and smoother once it is on AND with sensitive skin, I have never broken out from it. I could do without the smell that reminds me of bug spray but, I have honestly not been able to find anything else that works as well without all the added chemicals in it.
Love it!!
Posted 7/3/2010 by Michelle Sakatian
Just got my sunscreen just today! And I love it!!! I too have sensitive skin and can't use chemical based sunscreens, they irritate and or break me out! This sunscreen is amazing it is so light and feels like nothing on your skin. I love that it has a high Physical SPF coverage. I love it too, that it is not tinted.....Most Physical based sunscreens are tinted, please skinceuticals keep this one, it's absolutely exceptional:)sss
Best Physical Sunscreen
Posted 6/1/2010 by Anonymous
I have sensitive skin and can only use physical sunscreens. I've tried many that were either too heavy or left a white residue on my skin. Skinceuticals is the best! It's lightweight, absorbs instantly, leaves no white residue and does not make skin greasy during the day, nor cause breakouts. They advise to shake the product to activate ingredients. A tip I learned - do not shake with the cap on. You will find it ends up on the inside of the cap. I take the cap off, put my finger over the small opening and shake that way. It's a small bottle for the price so you want to make sure you don't waste a drop. I just wish for the price that the size would be a bit larger. I don't know if I could afford to use this everyday - it probably won't last a month. Other than that this is by far the best sunscreen I've used. Love it!
Fantastic for Oily/Sensitive Skin
Posted 4/29/2010 by Anonymous
This is an incredibly lightweight sunscreen that did not cause any problems for my very sensitive skin. No breakouts or clogged pores, which is a miracle, because most sunscreens cause me major problems with these, plus irritation. This is beautiful on its own or under makeup. Do not use this if you have dry skin because it will emphasize flakes. Well worth the price and skincarerx's customer service is the BEST! Don't miss this one!


text:
No American President has successfully campaigned for re-election on a platform of significantly higher taxes, yet that was the route embarked upon by President Obama yesterday when he called for the very wealthy to pay a higher rate.
In a clear move to step up his election campaign, Mr Obama used a speech on the economy in Florida to outline his support for the Buffett Rule, which would require the wealthiest Americans to pay tax at the same rate or higher than their employees.
Warren Buffett, the second-richest man in America, with a net worth of about $47 billion (£30


text:
Aktivity našich žáků v prosinci 2016
- Details
- 6. December 2016
V prosinci 2016 žáci naší školy i nadále úspěšně reprezentují školu při nejrůznějších příležitostech. Mezi nejvýznamnější aktivity našich žáků patří události, kterými se zabývají články v sekci ŽIJEME NAPLNO:
Another Victory of our Students
- Details
- 8. December 2015
Our school team achieved a landslide victory in the third year of the MAKRO HoReCa competition 2015. The final in the town of České Budějovice hosted a pentathlon for young chefs, and a barman and barista competition for young waiters. Our students cruised to victory in both these categories, and by doing so they won the overall first prize.
This is a great success for our school and it documents the hard work which all the members of our team have been putting in this school year. We would like to thank all of them for representing our school and wish them good luck in the events to come.
Brno Christmas Cup
- Details
- 13. November 2015
Brno Christmas Cup is an international competiton in beverage catering which is going to take place on December 14 in BEST WESTERN PREMIER Hotel International Brno.
The competition will be held in the two categories:
sommelier, bartender junior (age category U21)
For more information about the competition and on the registration process, please see the attached documents.
Job shadowing in Sweden
- Details
- 1. November 2015
Hej, hej, Stockholm!
The first week of October 2015 two teachers from our school, Ms Barbora Mitášová and Ms Gabriela Varmužková, took part in a Job Shadowing program in Sweden. They visited Stockholms Hotell- och Restaurangskola and Stockholms Internationella Restaurangskola where they were observing both theoretical and practical lessons as well as sharing and swapping experience in the field of TEFL with their Swedish colleagues.
They also presented our school and its study programmes, the Czech curriculum, discussed the opportunities to cooperate on various projects such as in the Erasmus+ and participation in students' profession competitions focused on particular branches provided at the schools involved.
Our teachers highly appreciated the warm and friendly atmosphere, really helpful staff and cooperative students at both schools!
Tack så mycket och ser fram emot att arbeta, Annika och Helena!
For more details, go to the links below J


text:
Adopting a pet can, like any commitment, be daunting. The promise of shared experiences leading to a lifetime bond soothes this twinge, however, and quickly replaces it with excitement.
Just think of the quirks you'll both learn to love about each other, the long walks or evenings spent reading by the fire, the companionship in both good and hard times. Falling in love is always a risk, but so is getting out of bed in the morning. Who knows what each day will bring? The only way to know is to take leaps of faith, both great and small.
Adopting is one such leap – giving another living being the power to change your life is the greatest gift you can give both them and yourself. Rescuing an animal in need can bring someone into your life who may, in turn, rescue you.
November is national Adopt a Senior Pet Month. Humane Societies and rescue groups all over the country are spending this month giving special discounts to adopters of senior animals, putting out senior-centric ad campaigns, and developing special programs to help senior pets find forever homes. If it seems odd to you that there is a whole month dedicated to such a specific faction of shelter pets, take into account that there are over 17,000 adoptable senior pets on Petfinder.com, the most commonly used search engine for rescues and shelters in the US. There are more than 10 adoptable senior animals at the Gastineau Humane Society in Juneau alone and a several of them have been adoptable and in the shelter for over a year.
Senior pets account for nearly 25 percent of Juneau's shelter population, but make up a much smaller fraction of monthly adoptions. It's our responsibility, as humans with both the resources to help and the understanding that age in no way depletes character or capacity to love and be loved, to close this gap.
Older animals are one of the toughest groups for shelters and rescues to place in homes, perhaps because adopters assume that you "can't teach an old dog new tricks." As animal lovers, however, we know better than to succumb to an adage. We know that an older animal is likely to be perfectly capable of learning the rules and customs of your home, and to be calmer, more reasonable, and to not beat around the bush about who they are and what they want.
When you adopt a senior pet, you both go into the relationship knowing what you're getting into and what you want out of it. You may each have undesirable habits or small incompatibilities that will need to be worked on, but what good, long-term relationship doesn't involve a little compromise and time invested? How often in life are we give the opportunity to be taken exactly as we are and loved for it unabashedly?
Truth be told, we're all going gray. For some it is only inside so far, but there are pieces of us time and worry have weathered nonetheless. This is not a burden – experience bears its own gentle beauty, as each gray hair on my head can tell you. There is no way I would trade one day of my fascinating, if a bit tumultuous, life for another year or two with a few extra brunette strands.
Such is the nature of living, that we are bettered by time and the opportunity to grow from the challenges it brings. This makes people hardier, stronger, and more interesting. Why should we attribute any less to the glimmering white on a dog's muzzle or the wisdom-filled eyes in a gray-flecked feline face? Their silver linings are a gift, just like ours.
• Irene Muller is a Kennel Technician with the Gastineau Humane Society.


text:
Expand Arctanx as a power series around 0 and integrate. You 'll get a new power series, whose radius of convergence can be calculated by the 1/limsup formula.
I've found a more challenging integral. I had trouble figure this one out.
Evaluate the indefinite integral as a power series. What is the radius of convergence?
the arctangent through me off.
also, INT (x - arctan x)/ x^3 dx


text:
Posted: 5:36 pm Tuesday, January 8th, 2013
Yum-demand prompts festival burger reboot at the Four Seasons
By M.M. Cloutier
Remember the burgers a sold-out crowd relished at the Palm Beach Food & Wine Festival's Burgers by the Beach event in December at the Four Seasons, the festival's host-hotel?
Food Network personality Robert Irvine served up a pimento-cheese slider with seared pork belly and Bravo TV's Top Chef fan-favorite Fabio Viviani offered a Prime beef short-rib burger, among others.
OK, if you weren't there, you don't remember any of this. At the time, the Burgers by the Beach event was the only chance to sink one's teeth into Four Seasons' Executive Chef Darryl Moiles' burger conceived specifically for the event—a Creekstone Farms beef and lobster burger.
Change of plans. Lingering buzz about Moiles' burger has prompted the Four Seasons to offer it on the menu this month at the resort's alfresco Atlantic Bar & Grill.
It stacks up this way: a plump Creekstone Farms Premium black-angus beef patty topped with lettuce, tomato, New England-style lobster salad and Moiles' "secret sauce" on a brioche roll.
The beef-and-lobster burger is $24; the oceanview and perpetual easy breezes are complimentary.
For more info, call the Four Seasons at 582-2800 or visit www.fourseasons.com/palmbeach.
About the Author
M.M. Cloutier is a longtime freelance journalist who has written and reported about dining and food, business, history, travel, people and more for numerous local, regional and national publications, such as Palm Beach-area newspapers and magazines, as well as The New York Times, Time magazine and others.


text:
engine light on wj i6 p0720
Anybody know where i can find the oss on that type of tranny? i think its diff then the v8 i cant find any pictures anywhere of it...:slapfight:
Re: engine light on wj i6 p0720
Hi Violat00.
The OSS is located i the rear af the tranny near the transfercase. The connector is a two wire type.
Best regards:-)
Re: engine light on wj i6 p0720
|All times are GMT -5. The time now is 07:48 AM.
Powered by vBulletin® Version 3.8.8 Beta 4
Copyright ©2000 - 2016, vBulletin Solutions, Inc.
Copyright 2012 - JeepGarage.Org
The Jeep Grand Cherokee Owners Community


text:
Clear and succinctInnovative
One of the essential skills that we bring to the table when writing grant applications for our clients is our ability to write clearly and succinctly.
When writing your first TSB grant application, you may feel that 3000 characters per question is a lot. You may struggle to come up with things to add to "fill up" all that blank space.
However, one of the signs of a grant application that's nearly ready is that you start having to cut things from many of the questions. When you're saying all that you need to say, 3000 characters is, in fact, very tight. It's very hard to properly pack a convincing business opportunity pitch, with supporting statistics and high-level narrative, into 3000 characters. It's even harder to do that while inspiring the reader so that they are enthused by your idea.
The worst thing you can do when struggling to answer the question is to ramble on without saying anything:
"Based on our extensive research, it is clear that the best mode of operation for achieving our desired objective is to focus a dedicated project onto the task of developing a new product."
This sentence says very little: 187 characters of fluff. Assessors are also likely to flag it as such, and downgrade your application because of it.
A better way to say more in less space would be:
"We conducted research with ResCo in 2010, and over 80% of respondents said they wanted a new product."
The latter is more concise and more specific, and therefore makes a more convincing case. And it's also shorter (101 characters), which means you can add more supporting evidence within the 3000 characters limit.
In summary, the challenge with grant writing is not to fill up fields with enough words – it's to make sure that every one of those words is adding value.


text:
See everything on sale inside our Latest Sale Flyer.
Shop Our Sale Flyer
Browse your favorite woodworking catalog!
Shop Our Catalog
Look up product instructions, videos and articles about your favorite tools using our Learning Center.
Join us on your favorite social network! Share your projects and learn from other woodworkers.
Please Note: This item can only be shipped ground to the 48 contiguous states. Some
items cannot be shipped via air due to being flammable, magnetic, contains batteries,
hazardous fumes or where contents are under pressure. Please use a physical address
not a PO Box during checkout.
(1 reviews)
Product Information:
Shipping / Billing Info:
(based on
of respondents would recommend this to a friend.
Displaying reviews
1 - 1
Back to top
Very Frustrated Customer
Woodworker Wayne
Euless, Texas
About Me
Best Uses
Comments about
Jet 10" ProShop 1-3/4HP 52" Fence, Cast Iron Wings, with Riving Knife, Model JPS-10TS
Very frustrating when you spend this kind of money on a Good Quality saw and when it arrives at you home it's missing parts and damaged parts from the factory. I noticed that the blade insert was cracked and upon further inspection the underside of it was hit by the blade when they tested it at the factory. Also the fence and rail assembly was missing the instructions and the tape for measuring along the rail was not in the box or affixed to the rail. Called and wrote emails about my problem but, nothing after a week of just looking at my saw wishing I could use it.
Bottom Line
No, I would not recommend this to a friend
Displaying reviews
1 - 1
Back to top
©2016 by Woodcraft Supply LLC


text:
Fresh and fast, these bowls of comfort can be ready in no time.
Vietnamese Beef-Noodle Soup with Asian Greens
Time: 30 minutes
Prep Pointer: Take care not to overcook the noodles, as they'll turn soggy in the soup.
Serve with Sesame Wontons: Cut 16 wonton wrappers in half diagonally; arrange on 2 baking sheets coated with cooking spray. Brush 2 teaspoons dark sesame oil over wrappers. Sprinkle evenly with ¼ teaspoon salt. Bake at 375° for 7 minutes or until crisp and edges are browned.


text:
I just need some support from people who "get" it. My almost six month old is in a "don't even think of putting me down to play, sleep, or just hang out for a minute" phase. I know it's just a phase...maybe teething, etc. BUT - it's so exhausting!! I can't get anything done! I do use a sling A LOT, but I just need a break. Usually she'll let my other (older) kids hold her and occupy her so I can get a shower, etc. But not this week. I look around and see everything that I should be doing, but am not. And although I KNOW taking care of my baby and older children is all I NEED to do, I still get frustrated. It doesn't help that I still only getting 2-3 hours of sleep at a time.
I know this time goes fast, but some days seem so LONG!
Just needed to vent. Thanks.


text: It all started quite boring and innocently with a rainy 6 hour drive from Melbourne to Canberra. I had eventually met up with Dominique, one of my travel buddies (formal introductions will have to wait until Katrina, our last travel buddy, arrives in a few days), in Melbourne. She had just come back from Canberra with a friend and we decided that the cheapest option for us to get north was to drive up again to Canberra with said friend. Continue reading


text:
After testing for Minardi in 2002 Franck Montagny became Renault's tester until the end of 2005, but never got a chance at a race seat. He did get a break when Super Aguri driver Yuji Ide was dropped after four rounds of 2006.
Montagny performed as consistently well as the uncompetitive car would allow him. He was dropped before he had the chance to race their new SA06 as a Japanese driver, Sakon Yamamoto, was put in the car to please the team's Japanese sponsors.
Montagny then signed to be the test driver for Toyota from 2007, but never returned to competition in F1, and later raced sportscars and in Champ Car.
Related links


text:
Ballot Must be
Received by MAY 1, 2012
William H. Crown, PhD, is President of the health care economics and late phase research businesses within OptumInsight Life Sciences. Dr. Crown came to OptumInsight after spending more than a decade at Thompson Reuters Medstat, where he was Vice President of Outcomes Research and Econometrics in the Research and Pharmaceutical Division. From 1982-1995, Dr. Crown was a faculty member at the Florence Heller Graduate School, Brandeis University, where he taught graduate courses in statistics and conducted research on the economics of aging and long-term care policy. He was Director of Policy Studies in the Policy Center on Aging from 1989-95, and Faculty Chair of the Heller School from 1992-93. He received his doctorate degree in urban and regional studies from the Massachusetts Institute of Technology, and a master of arts in economics from Boston University. The author of two books and co-author of two others, Dr. Crown has published more than 100 peer-reviewed journal articles, book chapters, and other scholarly papers. Known for his early application of sample selection bias models in the pharmaceutical outcomes research literature, he is a frequent speaker on pharmaceutical economics and econometric methodology at professional meetings and conferences. In addition to his management role within OptumInsight Life Sciences, Dr. Crown is Chair of the OptumInsight Fellows Program and a UHG Innovation Champion. In these latter roles, he applies his expertise in statistical methodology to a wide variety of problems in health care--ranging from the design of comparative effectiveness research studies to the evaluation of disease management programs.
Dr. Crown has been a member of ISPOR since 1998 and has served on numerous ISPOR Task Forces over the years including the ISPOR Task Force on Retrospective Databases, ISPOR Task Force on Real World Data (Economic Subgroup), and the ISPOR Task Force on Good Research Practices for Retrospective Database Analysis. He has also served on the ISPOR Institutional Council since 2004 and taught ISPOR Short Courses on retrospective database analysis at both the ISPOR Annual International Meetings and ISPOR Annual European Congresses.
ISPOR Vision Statement by William H. Crown, PhD
With its Vision 2020 effort, ISPOR leadership has placed considerable emphasis on charting ISPOR's path for the next decade. However, when I think about how ISPOR has evolved over the years, I am particularly struck by its emergence as a truly global organization. ISPOR has experienced remarkable growth since it was established in 1995 - from a few hundred initial members to nearly 11,000 (including the ISPOR Regional Chapter members) in 2012. In the past two years, attendance at the European Congress has outpaced the International Meeting held in North America and attendance at ISPOR regional conferences in Asia and Latin America (on a rotating bi-annual basis) have grown.
There is tremendous benefit to the sharing of experiences among ISPOR members with respect to national policy initiatives in our respective countries. I suspect that many of my non-US colleagues have been amused at the focus on 'comparative effectiveness research' (CER) in the United States. The emphasis of CER on real world evidence regarding treatment effectiveness and safety extending beyond just drugs to surgery, behavioral health, disease management, health care organization, and more looks a great deal like the emergence of health technology assessment (HTA) in Australia, Canada, and Northern Europe 20 years ago.
Many of the new treatments being developed by biopharmaceutical and medical device companies have the potential to save lives and improve the quality of life for countless patients. But the challenge of managing spiraling health care costs continues to grow. ISPOR's focus upon the science and methodologies needed to generate high quality evidence to inform decision-making by physicians, patients, regulatory bodies, payer organizations, and other health care stakeholders positions the organization to have a tremendous impact on the lives of patients and the future path of health care. I am passionate about this focus and would love the opportunity to work with all of you to continue to develop the impact of ISPOR on health care around the world.
Marcus Wilson, PharmD, is President of HealthCore, WellPoint's wholly owned research subsidiary, which he co-founded in 1996. He has been extensively involved in health economics, outcomes and epidemiologic research for more than 17 years. While on faculty at the University of Sciences in Philadelphia in the early 1990's, he led efforts at Blue Cross Blue Shield (BCBS) of Delaware to evolve the drug formulary development process from the traditional pharmacy and therapeutics (P&T) approach to a broader health outcomes management process that incorporated comparative effectiveness research endpoints, including value-based assessments, and disease management pull-through programs into the decision-making process. It was during this time that Dr. Wilson helped develop clinical trials, outcomes research and patient education programs within a division of BCBS Delaware which was purchased from BCBS in 1996 and used as the foundation of HealthCore.
Dr. Wilson received his Bachelor of Science in biochemistry from Virginia Tech and his Doctor of Pharmacy degree from the Medical College of Virginia. He joined the faculty of the University of the Sciences in Philadelphia (USP) after completing his residency in family medicine at the Medical University of South Carolina and spent seven years with USP in a didactic and experiential training role for doctor of pharmacy students.
In addition to his role as President of HealthCore, Dr. Wilson serves as member of the FDA Mini-Sentinel Program's Project Operations Council, the Brookings Active Safety Surveillance Council (BASIC), the eHealth Initiative Board of Directors, the Observational Medical Outcomes Partnership (OMOP) Executive Board and the Board of Visitors for the Mayes College of Health Care Business & Policy at the University of Sciences in Philadelphia. He is a past member of the ISPOR Board of Directors (2003-2006) and serves on the ISPOR Vision 2020 Strategic Plan Task Force. He is also a reviewer for multiple scientific journals. His publications, including book chapters, span various clinical, health care safety and health outcomes topics.
ISPOR Vision Statement by Marcus Wilson, PharmD
We are at a unique point in the evolution of health care systems globally. Health care related costs are continuing to escalate at an alarming rate; new payment models are shifting risks and modifying incentives; and health information technologies are rapidly evolving and changing information flow and data availability. In addition, real world outcomes, including quality and total cost of care, are taking center stage as a means to solve the seemingly irreconcilable conflict between increasing access and improving quality while controlling costs. Within this evolution, the health economics and outcomes research community is in a very unique and highly valued position, in part due to the vision and leadership of ISPOR. Since its founding in 1995, ISPOR has taken great strides towards achieving the mission to increase the efficiency, effectiveness and fairness of health care decisions. It has become a nexus for global stakeholders to meet, share ideas, discuss concerns and derive solutions to some of our most pressing issues.
Though collectively we have made tremendous progress over the last two decades, much still remains to be done to improve research methods, enhance access to high quality data, accelerate evidence generation and its incorporation into decisions and cultivate and expand a high quality workforce. As costs and quality of care concerns continue to mount and apprehensions around the lack of generalizability of traditional clinical trials results grow, health care decision makers are increasingly demanding more and better information on new and existing technologies that facilitates decisions that result in improved quality, safety and total cost of care in their population. Similarly, payers and providers are progressing toward new outcomes-based reimbursement models that will be dependent upon the accurate and timely assessment of clinical, economic and humanistic endpoint.
ISPOR is well situated to continue its significant contribution to the construct of the fundamental frameworks for the transition to outcomes-based health care systems across the globe. We will do so through multiple means including facilitating the dissemination of knowledge, encouraging innovation and new methods development and fostering cross-stakeholder collaborations.
The future is bright for our industry. As the primary society for health economics and outcomes research, ISPOR is ideally positioned to serve as a critical catalyst for continued change and improvements in the means by which outcomes of care are predicted, measured and disseminated for decision support. It would be my honor to lead you as president for a portion of this journey and contribute my experiences from within the research, payer, academic and health care delivery systems to the broader vision of ISPOR.s
Jan Busschbach, PhD is a Professor of Health Related Quality of Life and the Head of the Department for Medical Psychology of the Erasmus MC in Rotterdam. He is also the Managing Director of the Viersprong Institute for Studies on Personality Disorders (VISPD). He received his training in health economics at the Institute for Medical Technology Assessment (iMTA) in Rotterdam, and has been the General Director of that Institute from 1999 till 2002. His main research topic is the integration of health related quality of life outcomes into cost effectiveness analysis. He also has a special interest in the operationalization of arguments other than cost effectiveness arguments in health technology assessment (HTA), such as distributional and ethical considerations.
Currently, Dr. Busschbach is the Chair of the EuroQoL Foundation and member of the committee that advises the Dutch Health Care Insurance Board on reimbursement of new drugs (CFH). In close collaboration with clinical researchers, he has been working on health economic studies in a broad range of medical disciplines, such as endocrinology, nephrology, dermatology, oncology, urology, infectious disease, rehabilitation, and psychiatry.
ISPOR Vision Statement by Jan Busschbach, PhD
A gap exists between state-of-the-art health economic / health technology assessment (HTA) research and actual reimbursement decision making; and this gap is wider than the gap between clinical research and reimbursement decisions. It is possible that health economics and outcomes research have become sophisticated too fast to catch up. Or could it be that health economics and HTA cannot satisfy the needs of decision makers: even a state-of-the-art and valid cost effectiveness analysis may not necessarily be a decisive argument in reimbursements decisions. On the one hand I would therefore plea for support of the ISPOR efforts to provide accessible education and information especially targeted at the decision makers. On the other hand, ISPOR should stimulate the awareness among researchers that health economics and HTA are, in the end, tools for decision makers, and that researchers should find ways to provide the warranted information for decision makers in a comprehensive way. Providing a stimulating environment for debate between decision makers on the one side and researchers and industry on the other is, in my opinion, an effective way to overcome the gap. Providing such a stimulating environment for debate is a strong ISPOR asset, although the voice of the decision makers has been louder in the past. Stimulating the participation of decision makers in the ISPOR community would be my goal for 2012-2014.
Gérard de Pouvourville, PhD, is presently Chair Professor for Health Economics at ESSEC Business School, one of the three major business schools in France. Formerly, he has led a career as a researcher in the field of health care economics and management, at Ecole Polytechnique, at the French National School of Public Health and at the National Institute for Health and Medical Research (INSERM). His main contributions have dealt with hospital funding and management, physician payment scheme, health technology assessment and pharmacoeconomics, and health policy. He is a member of the EUROQOL group and has published the French tariff for the EQ-5D questionnaire. He has been on the editorial board of the European Journal of Health Economics (EJHE).
Dr. de Pouvourville is the former Chairman of the French Health Economists College and is currently Vice President. He has been Vice President of the National Observatory for the Prescription and Usage of Drugs, from 2000 to 2003, and has been a scientific advisor to the French Ministry of Health on hospital funding systems and reforms for the past twenty years. He also sits on the Scientific Committee for the French National Sickness Fund. He is a consultant for major pharmaceutical companies.
Dr. de Pouvourville has published articles in EJHE, Value in Health, International Journal of Technology Assessment in Health Care, and other medical journals. He has edited two books on prospective payment schemes for hospitals with Professor John Kimberly, University of Pennsylvania, and Thomas D'Aunno, from Columbia University together with books in French on international comparisons of health care systems and initiation to health economics. In 2009, Dr. de Pouvourville was Research Review Committee Co-Chair for the ISPOR 12th Annual European Congress in Paris, France. Currently he is a member of the ISPOR Performance-Based Risk-Sharing Agreements Good Research Practices Task Force.
ISPOR Vision Statement by Gérard de Pouvourville, PhD
As a health economist, I am particularly impressed by the achievements of ISPOR since its founding and as such honoured to have been nominated as a Director candidate. Amongst ISPOR activities, its capacity to bring together scholars, business representatives, public and private payers, to discuss methodological issues and define good practices for health technology assessment is what I appreciate most. Having been involved in the preparation of the ISPOR 12th Annual European Congress in Paris, France, I have also come to know its organisational skills and strong requirements for quality. Finally, ISPOR is now the largest international forum around health technology assessment. This being said, how can I contribute to ISPOR as a Director? First, concerning Europe, there are still major differences in approaches to the use of health economics in public decision making around access to new technologies; nevertheless, there are signs of convergence between national models around the role of health economics. To me, ISPOR seems to be a place to contribute to this convergence, through debates in ISPOR Task Forces, and in the organization of plenary sessions and issues panels during the Annual European Congress. Second, as I am very much involved in the French Health Economist Association, where I hold the position of Vice-President, being a Director at ISPOR is for me the opportunity to increase interactions between French scholars and also decision makers and the international community. Third, to broaden my scope, I am quite eager to contribute to the strengthening of younger chapters, in particular in the Asia Pacific region, where my school, ESSEC, is developing both teaching and research in health economics.
Marcelo Fonseca, MD, has a Master's Degree in Health Economics and Management, and is the current Vice Chief of Staff of the Dean of the Federal University of São Paulo (2009 - present). Dr. Fonseca is a Professor in the Medical and Health Technologies School at the Federal University of São Paulo where he teaches courses to undergraduate and graduate students in health technology assessment, clinical research and pediatrics (2005- present). He is the head of the Women's Health Technology Assessment Center at the Federal University of São Paulo (2011 - present). He is the founder, first CEO and now member of the Board of Directors of the Clinical Trials Office of Federal University of São Paulo, where more than 500 clinical trials take place every year (academic, government and industry sponsored trials). In the past he has worked as Medical Manager, Product Manager and Group Product Manager of Oncology and Hematology products (1997 - 2000), Latin American Leader for Hematology (1999 - 2001) and Business Unit Director responsible for market access, health economics and clinical trials (2000 - 2003) at Hoffmann La Roche Inc (Brazil).
Dr. Fonseca obtained his Medical Degree at the aforementioned University (1984 - 1989), and is a specialist in pediatrics and pediatric critical care medicine, has his own pediatric practice and is staff physician at several major hospitals in São Paulo, including the Albert Einstein Israeli Hospital. He received his Master's Degree in Health Economics and Management at Federal University of São Paulo (2002 - 2004). Presently, he is a PhD student in sciences.
In 2003, he founded Axia.Bio Consulting, the first consulting company in Brazil specialized in health economics and outcomes research and also one of the first HTA companies in Latin America. His research production and publication in national and international peer-reviewed journals is concentrated in health technology assessment, health economic evaluations and in pediatric critical care medicine.
Dr. Fonseca has served ISPOR in various capacities in the last several years. He is the Education Director of the ISPOR Brazil Chapter (2006 - present), the first Latin America ISPOR Chapter, of which he was one of the founders (2006). He has acted on the organizing committee of the 1st and 2nd ISPOR Brazil Chapter Congress and is the Chair-elect of the ISPOR Latin America Consortium Distance Learning Committee. He was also a reviewer for the Portuguese translation of Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms.
ISPOR Vision Statement by Marcelo Fonseca, MD
I am really honored to serve as a Director candidate for the ISPOR Board of Directors. Health systems around the world are being re-thought, adjusted and affected by the necessary changes to accommodate ever increasing health care costs with finite availability of funding resources. Thus, health technology assessment (HTA) continues to gain importance around the world. ISPOR, as the leading society dealing with HTA and outcomes research, should act as a catalyst of such changes, using the experience and diversity of its members to offer and provide a balanced view of many health care policies around the globe and their possible changes. To this end, I propose to support ISPOR in the following ways: 1 - to foster partnerships with other professional societies (e.g., physicians, pharmacists, health service auditors, economists), service providers (e.g., hospitals and diagnostic services) and payers, similar to what the ISPOR Brazil Chapter has done in recent years; 2 - to provide a forum to conduct open discussions among the participants in this market, including patients, through representative groups / associations; 3 - to encourage our members to use their expertise not only to produce data and evidence, but also to effectively engage in decision making in their markets; 4 to maintain and strengthen the scientific rigor of HTA activities around the world, primarily through the dissemination of good practice guidelines; 5 - to stimulate the entry of new members and foster their education, as I have been promoting throughout my career, not only through graduate courses but also through internships with health care providers, industry and government; 6 - to maintain one of the most outstanding features of this Society, which is the ability to listen to their members; 7 - to support the growth and consolidation of the ISPOR Latin America Consortium and the ISPOR Regional Chapters. I believe I can continue to significantly serve ISPOR in achieving its mission, by striving to make the above proposed actions happen, by serving as a strong representative of the Latin America region on the ISPOR Board of Directors and by bringing reality to the diversity and multicultural character of this organization.
Yajaira Bastardo, PhD, is Professor of Pharmacoeconomics and Pharmacy Administration at the Central University of Venezuela in Caracas, Venezuela.
She also teaches graduate courses in pharmacoeconomics for the Sanitary Surveillance of Medicines Program of the National Health Institute "Rafael Rangel" in Caracas, Venezuela and in the Master of Pharmaceutical Sciences at the University of the Valley of Guatemala, Guatemala City.
She received her BSc (Pharmacy) degree from the Central University of Venezuela and in 2001 she completed a PhD in Pharmacy Health Care Administration at the University of Florida, Gainesville, FL, USA.
Dr. Bastardo has served the School of Pharmacy as Administrative Director (2010-11), Chair of Pharmacoeconomics and Pharmacy Administration, Coordinator of the Health Care Program, Chair of Applied Microbiology, and Coordinator of the Applied Microbiology Program. She has conducted research and published in health outcomes research. Her primary research interests include quality of life, health-care decision making and pharmacoeconomics.
Dr. Bastardo has served ISPOR in several capacities: ISPOR Venezuela Regional Chapter Founder and inaugural President; ISPOR Latin America Consortium Executive Committee member; ISPOR Biennial Latin America Conference Short Course Program Committee Co-Chair; ISPOR 3rd Latin America Conference Research Committee Co-Chair; ISPOR 2nd Latin America Conference Workshop Committee Co-Chair; and currently as a member of the ISPOR Vision 2020 Implementation Task Force.
ISPOR Vision Statement by Yajaira Bastardo, PhD
I am really honored to be nominated for this Director position on the ISPOR Board of Directors. Founding members envisioned ISPOR as a truly international, multi-disciplinary professional membership society which advances the policy, science, and practice of health outcomes research. In less than two decades, ISPOR has become the most important international association in the fields of health economics and outcomes research with more than 50 ISPOR Regional Chapters and a presence around the world.
ISPOR, with a membership trained in multiple disciplines, working in different environments, and responsible for conducting research or translating that research into informed health care decisions and policies around the world is well-suited to take advantage of the opportunities and challenges for outcomes research that globalization of the economic crisis and health care is offering.
As a pharmacoeconomics professor and heath care professional from Latin America, I am strongly committed to the ISPOR mission. Over the recent years, I've had the privilege of contributing to ISPOR activities in Latin America and I am looking forward to continuing to foster excellence in pharmacoeconomics and outcomes research within in the region and abroad.
Kenneth KC Lee MPhil, PhD, is Professor of Pharmacy and Head of Pharmacy, School of Medicine and Health Sciences, Monash University, Malaysia. Before he moved to Malaysia, he was Professor and Associate Director (External Affairs) of the Chinese University of Hong Kong (CUHK) School of Pharmacy where he was one of the founding members and had subsequently worked for 18 years.
Dr. Lee received his pharmacy undergraduate training from the University of Washington in Seattle. His subsequent higher qualifications were from the CUHK and the University of Oxford, UK.
He is widely recognised as one of the pioneers in pharmacoeconomics and outcomes research in Asia focusing on comparative effectiveness research, health technology assessment and healthcare policy development. He has published extensively in peer-reviewed international journals. He has been the Editor-in-chief of the Journal of Medical Economics since 2006 and is serving on the editorial board of a number of international journals including Value in Health. He is also Adjunct Professor of School of Pharmacy, the CUHK; Honorary Professor of School of Public Health, the University of Hong Kong; and was visiting Professor of University of London School of Pharmacy from 2008-11.
Dr. Lee has served in a number of positions in ISPOR. He was the major driving force and later a founding member of the first ISPOR regional consortium - ISPOR Asia Consortium which was established in 2004. He served as chair of the Consortium from 2006-8. Before this, he also spearheaded and became the founding chair of the first ISPOR regional chapter in Asia - ISPOR Hong Kong Chapter in 1999. He was a member of the organizing committees of several ISPOR Asia Pacific Conferences from 2004-2011. He had also taught in a number of ISPOR short courses. Currently he is chair of the ISPOR Asia Consortium Publication Committee, and he has recently been appointed as Co-Editor of Value in Health Regional Issue.
ISPOR Vision Statement by Kenneth KC Lee BSc(Pharmacy) MPhil, PhD
Ever since its inception 15 years ago, ISPOR has been working unfailingly towards improving and engaging with stakeholders in the discipline of health economics and outcomes research. The achievements have been unanimously regarded as highly successful by all standards. But we are in no position for complacence. I see the next 15 years as being even more challenging yet more rewarding for ISPOR due to the high speed at which health technologies are advancing and all the upcoming healthcare reforms in different jurisdictions all over the world. Our Society is in the best position to ride on these opportunities to further enhance the science of outcomes research with the ultimate objective of translating the science into practical and useful information for all stakeholders. ISPOR should keep its far-reaching vision as an international Society thus strengthening the link among the audience across nations and cultural backgrounds. As the largest and most recognised organization in the field, I see another major responsibility of ISPOR in nurturing scientists of the next generation to ensure a more advanced and more efficient system of healthcare delivery in the next few decades. My academic background in research and education over the last 25 years, together with my extensive international experience will definitely help me to serve all ISPOR members more comprehensively.
Jawahar S. Bapna, MD, PhD, is Director, Jaipur College of Pharmacy and Emeritus Professor, SMS Medical College, Jaipur, India. He trained at National Institutes of Health (NIH), Washington, DC, and Karolinska Institute, Sweden and has over 35 years of academic experience involving teaching and clinical research. He led the team conducting clinical trials and bioequivalence studies in various institutions in Delhi and Pondicherry. He has been a member of various committees of the government including Indian Pharmacopeia Committee and the Essential Drugs Committee. Working with the WHO-India Essential Drugs Program, he developed the Medicines Policy in various states of India. He has served on the faculties of Delhi, Rajasthan, Pondicherry and Madras Universities. He has been the President of Indian Pharmacological Society.
Dr. Bapna has presented his work at several local, national, and international conferences and has 72 peer-reviewed publications, including articles in Value in Health, Pharmacoeconomics, Lancet, Health Policy and Planning, and more. He contributed to WHO's Guide to Good Prescribing, their bestselling book published in more than dozen languages. has received numerous awards for his work and has been an invited lecturer in the Asia, United States and Europe. He has worked on research projects specializing in the development medicines policies for promotion of rational use of drugs and improved access at low cost to the people with WHO, World Bank, EU, Futures Group, and more. He has been a member of the Strategies for Enhancing Access to Medicines Program (SEAM) team of the Management Sciences for Health (MSH) that works on 'targeting improved access to medicines'.
ISPOR Vision Statement by Jawahar S. Bapna, MD, PhD
The mission of ISPOR (at a local level) is: to provide an environment for knowledge sharing among researchers, health care practitioners and decision makers interested in pharmacoeconomics and outcomes research; to serve as a bridge in bringing together (Indian) researchers, health care practitioners, and decision makers interested in pharmacoeconomics and members of pharmaceutical industry, health-related organizations, and academia; to act as a resource at a local level for individuals including students interested in pharmacoeconomics and outcomes research; and to provide an opportunity for members to become more familiar with the activities of ISPOR as well as participate in its activities.
With a growing international presence through regional meetings and interest groups, ISPOR is a focal point for decision making on costs and outcomes of health care interventions. With particular interest in regulatory affairs, ISPOR contributes to the growing efforts to maintain and improve access to effective medical treatments blending the interests of all stakeholders in health care decisions. Through dissemination channels, particularly annual and regional meetings and the widely read journal, Value in Health, important policy and methodological issues can be shared. ISPOR Task Forces provide a collaborative arena for considering issues and offering potential solutions. Workshops, forums, and plenary sessions at ISPOR meetings keep the current problems and solutions in front of our constituency.
Zoltán Kaló, MSc, MD, PhD, is Director of the Health Economics Research Centre, Department of Health Policy and Health Economics, Eötvös Loránd University, Budapest. He has more than 15 years of international experience in academia and industry, specializing in health systems design, health technology assessment, outcomes research, economic modeling and strategic pricing of health care technologies. He is a founding member and President-elect of the Hungarian Health Economics Association, Board Member of the Hungarian Society of Personalized Medicine and of the Hungarian Medical Professional College in Health Care Management and Health Economics, and a member of many international scientific organizing committees.
Dr. Kaló holds an MD and a PhD in Pharmaceutical Sciences from Semmelweis University, an MSc in Health Economics from the University of York, and a Dr. Habil in Sociology from Eötvös Loránd University. He is a director of post-graduate programs in pharmaceutical policy and pharmacoeconomics, and in health policy, planning and financing; his research has been widely presented and published in leading journals, and he serves as a policy advisor to global health care corporations, public decision makers and the European Commission. Dr. Kaló is the founder and CEO of Syreon Research Institute, an international research corporation specializing in health economic modeling and technology assessment.
Dr. Kaló is an active member of ISPOR and ISPOR Chapter Hungary President-elect. He contributed to several events and forums of the Society, especially in Central and Eastern Europe.
His most recent research is related to the allocation and efficiency of health care financing and implementation of local and international health care and industrial policies, with special focus on middle income countries and emerging economies.
ISPOR Vision Statement by Zoltán Kaló, MSc, MD, PhD
The tremendous success of ISPOR is proof of the need for an international multidisciplinary organization to advance the policy, science and practice of health outcomes research. I fully support the vision and mission of the Society, and I am honored to be a candidate for an ISPOR Director position.
Several high-income countries in Western Europe, North America and Asia Pacific regions have been successful in implementing the mission of ISPOR to improve global health through facilitating evidence-based decisions. Because of the lower health status and more limited resources for health care of their population, the implementation of evidence-based health policy in middle income countries has been less successful. In these countries there is still enormous room to promote local outcomes research, to build capacity in the multiple disciplines of outcomes research, to facilitate discussions among key stakeholders and to communicate results of research to policy-makers more efficiently. There are reasonable differences between high-income and middle income countries, especially in the availability of local data, financial and human resources for outcomes research, the relative price level of new health technologies, and finally in the culture of transparent decision making. These differences need to be taken into account in the future scientific and organizational development of ISPOR and the society has already made important steps into this direction by establishing regional chapters, facilitating regional congresses and launching the new journal, Value in Health Regional Issues.
Regardless of the outcome of my candidacy I am dedicated to support the implementation of ISPOR VISION 2020 with special focus on middle income countries.
Karina Jahnz-Rozyk, MD, PhD, is a Professor and an expert in the fields of allergology and clinical immunology with a diploma in medicine received from the Medical University, Warsaw, Poland. Dr. Jahnz-Rozyk's academic degrees and scientific titles include a doctoral degree and habilitation (postdoctoral) degree in allergology. Since 2003, she is the Head of Department of Allergology and Clinical Immunology at the Military Institute of Medicine. In 2002 she was nominated a Professor in Allergology and Pneumonology. She is an active member of the Polish Society of Allergology, European Academy of Allergology and Clinical Immunology, European Respiratory Society. Since 2003 she has been a member of the Polish Society of Pharmacoeconomics (ISPOR Poland Chapter) and in 2009-2012 she has served as President of the Society. She is the author and co-author of 330 publications. She supervised 22 clinical trials (II&III phases) in the areas of respiratory and allergic diseases. Her scope of interest in pharmacoeconomics covers costs of diseases, particularly in chronic obstructive pulmonary diseases (i.e. COPD and asthma) with a focus on outcomes research (e.g. clinical trials (RCT) and HRQoL). Her efforts focus on advocating for strengthening the relations between clinical and economic effectiveness. As the President of the Society she broadened her interest in the management of the public health care system in Poland and therefore she joined the Economic Commission at the Ministry of Health, the main goal of which is to implement the current and novel reimbursement system in Poland. Furthermore she is the organizer of the Annual International Conference of Polish Society of Pharmacoeconomics. During her presidency she has actively participated in conferences, meetings and forums of the ISPOR European Chapters as well as contributing to the successful efforts in the promotion of pharmacoeconomics and outcomes research science in Poland. During the term of her service as the ISPOR Poland Chapter President, guidelines for pharmacoeconomics analysis were updated. She is also the co-editor of the Polish translation of Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. She also served as the editor in chief of the PTFE ethics code inspired by ISPOR achievements.
ISPOR Vision Statement by Karina Jahnz-Rozyk, MD, PhD
In my view the mission of ISPOR is to increase the efficiency, effectiveness, and fairness of health care use to improve health. The ISPOR vision is to make the society recognized globally as the persuasive authority for outcomes research and its use in health care decisions towards improved health. The ISPOR scope and sphere of influence includes outcomes researchers, health technology developers and assessors, regulators, health economists, health care policy makers, payers, providers, patients, populations, and the society as a whole.
If chosen as a member of the ISPOR Board of Directors I commit myself to my vision of ISPOR which includes the following activities: 1) execution of ISPOR mission in the countries of Central and Eastern Europe, 2) facilitation of the introduction of novel mechanisms in the process of the registration of drugs and their assessment by health technology assessment agencies as well as their reimbursement and availability to patients in middle income countries, 3) strengthening the role of ISPOR with educational activities in the fields of pharmacoeconomics and outcomes research in middle income countries, 4) contribute to the creation of a forum to facilitate the interchange of scientific knowledge in pharmacoeconomics / health economics and patient health outcomes, and encourage communications among the research community, health care professionals, and other research, regulatory, and educational groups, including communications with media and the general public by educating public and private agencies on the usefulness of research in pharmacoeconomic and patient outcomes assessment, 5) facilitate the translation of ISPOR publications into the languages of individual countries with ISPOR Regional Chapters, 6) facilitate pharmacovigilance research of new drugs in particular ( e.g. biological, biosimilar).
I wish to express my strong belief that my Vision for ISPOR will contribute to the development of the Society.
Contact ISPOR @ firstname.lastname@example.com
| View Legal Disclaimer
©2016 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
Website design by Eagle Systems USA, Inc.


text:
What is in this article?:
- One chance to get variety selection right
- Important tools
- Diversity should be part of the variety selection process.
- Yield and lint quality characteristics are important considerations for cotton growers.
- Variety trials, replicated across sites and across seasons provide good data for decision-making.
More About:
DAVID DRAKE, Texas AgriLife Extension agronomist, San Angelo, says variety selection is one of the most important decisions a cotton farmer will make. And he has to make it early.
One chance. One chance with thousands and thousands of dollars on the line. Cotton farmers have one opportunity, before they have any clue of what kind of season they are likely to have—rainy, dry, colder than usual or hot as blazes—one shot at picking the right variety to mesh with whatever conditions come along during the long growing season.
David Drake, Texas AgriLife Extension agronomist at San Angelo, compared the decision-making process a cotton farmer goes through early in the year to a professional baseball manager who has 162 chances from April into October to switch things around and put the best team on the field. A coach for professional basketball or hockey has 80 opportunities to change his mind. College basketball skippers have 30 opportunities; the NFL gets 16—asssuming they don't go to the playoffs—and NCAA football has 12 chances, unless they are fortunate enough to get into one of the 30 or so post-season bowl games. And even rock, paper scissors players usually go two out of three, Drake said.
But a cotton farmer has to decide, sometimes as early as January, what varieties are most likely to give him the best chance of making a decent yield and a profit. "A farmer has to make his pick early and be prepared for conditions in July and August, Drake said during the recent Concho Valley Cotton Conference in San Angelo.
"It's an important decision," Drake said. And farmers have a list of reasons why they choose one variety over another—some reasons better than others. Peer pressure may play a role. Tradition, planting what he's planted for years, may be a factor. Also weighing in on the decision-making process is the relationship a farmer has with his seed dealer, favorable terms available from one company, performance—yield and quality—agronomic or system fits, and traits. A few other issues could affect variety choices as well.
But Drake says diversity should be part of the process. "Select and plant two or three different varieties. At a minimum, plant two that are familiar and maybe plant one new one to see how it performs.
If you are enjoying reading this article, please check out Southwest Farm Press Daily and receive the latest news right to your inbox.
"Make certain the variety fits the system, including the equipment available and performance goals. Quality or a market producer may be a good choice. It's becoming more and more important to plant what the consumer wants."
Drake says if farmers wait three years, some decisions will be made for them. Older varieties will be retired as new ones come on board.
"Varieties change fast and the current ones may no longer be available within a few years." Consequently, farmers must constantly update their knowledge of new options "to be able to make the best choices."


text:
Bible Baptist Fellowship Church
Southern Baptist Convention
360 North State Street
Harrison, OH 45030
Bible Baptist Fellowship Church is a small church located in Harrison, OH. Our church is associated with the Southern Baptist Convention (SBC).
What to Expect at Bible Baptist Fellowship Church
James Hundley, Pastor
Jim Upchurch, Associate Pastor
Service Times:
Sunday School 10:00am
Sunday Worship 11:00am
Sunday Evening Service 6:30pm
Wednesday Evening Service 6:30pm
Service Details
- Informal or casual attire most common
- Traditional worship style
- Printed worship bulletin
- Location: Hamilton County
Ministries and Programs
- Information not available
Additional Info About Our Church
Bible Baptist Fellowship Church is a small friendly informal church.
360 N State St, Harrison OH 45030
View larger map and directions for worship location
View larger map and directions for worship location
Add or Update Church Listing Info
Add or update the information in this church listing to help visitors discover Bible Baptist Fellowship Church.
For Further Information
|(513) 647-2346


text:
Everyone gets pissed off sometimes. Occasionally, even the most even-headed among us will overreact in childish ways, such as locking your boyfriend out of the car or calling your girlfriend "the Devil." But there are some people who take petty revenge to dizzying levels of perfection.
7Getting a Bunch of Scientists to Sign a Paper Saying You're Stupid
Being a scientist has to be tough. They spend their days staring down microscopes, knowing full well that when someone asks, "What do you do for a living?" any answer they give is going to elicit nothing but blank stares.
Via WhatWouldOakleyDo
"Whatever. I'm just in it for the sweet ninja outfit."
When it comes to dealing with people who believe in creationism, it's got to be especially tough. Typically, scientists shrug it off as a fact of life, knowing that no matter how much evidence they collect, some people will simply never accept it.
Creationists tend to be less resigned, and often try to prove the legitimacy of their theory by compiling lists of scientists who doubt evolution. All in all, hundreds of these lists are circulated. When you take a close look at the list of supposedly well-respected members of the scientific community, you notice that they often include television writers and lawyers, and that the people listed as actual scientists either weren't actual scientists, completely disagreed with that statement they supposedly agreed with, or don't actually exist.
It was exactly as relevant as a Flogging Molly set list.
Deciding they'd had just about enough of this bullshit, The National Center for Science Education decided to compile a list of their own -- one with very, very strict guidelines. Each scientist who signed had to agree that creationism was, in fact, silly and that it should not be taught in schools. They had to be from an area of science where their expertise was actually pertinent and, finally, because this apparently needed to be stipulated, they had to be an actual scientist. Oh, and in order to sign, you had to be named Steve or a variant thereof. As it stands, over 1000 Steves are on the list, including Stephen Hawking.
Explaining the reasoning behind the stunt, the scientific community noted that they could have easily compiled a contradicting list of tens of thousands of signatures. But focusing on scientists not named Steve would have taken too much time, and they had things to do.
Via Universe Today
Like building this.
6Putting a Bear on Your Property
Lord Byron is considered one of the greatest English poets ever. Normally, words such as "badass" don't belong in the same sentence as "poet" -- something Byron was keen to change. Despite having a club foot and a crippling eating disorder for virtually his entire life, the poet managed to earn a reputation as an extravagant, melancholic, courageous, unconventional, eccentric, flamboyant and controversial figure. Or to translate: He owned all of the sex.
Via Wikipedia Commons
All of it.
When not boning his way through the aristocracy, Byron was really into his pets in a way that was less like a cat lady and more like the Beastmaster. When he went to college, he tried to take his pet dog with him. Cambridge Trinity College was having none of it and stuck to their strict "no dogs allowed" policy, seemingly unaware that they were currently talking to Lord Fucking Byron. After being told no, Byron pleaded with the college to make an exception, but they wouldn't budge.
Seeing an opportunity to display the subtle dignity of the poetic soul, Byron went out and purchased a bear, then brought it to Cambridge.
That's right. Soak it in.
It didn't take long for college officials to notice the abnormally large portion of the student body running in the same direction while screaming , "AAAAAHHHHH BEAR!" When they confronted him about the fact that he was essentially wagging his dick at them in front of everyone, Byron simply asked them to show him where in the rules it said that he couldn't have a bear. Amazingly, there wasn't a specific rule against it. Even more amazingly, Cambridge apparently operated on sitcom logic at the time, and officials decided they had no choice but to allow the bear to stay. Presumably they knew that if they did manage to evict the bear, Byron would have simply arrived to campus the next day riding a sled pulled by tigers.
Via Wikimedia Commons
"Please don't make me buy a Minotaur."
Byron lived quite happily with his pet bear, but he wasn't done taking a piss on officials just yet, so he sent a sarcastic letter to the college suggesting that the bear should apply for a fellowship. Eventually, to everyone's relief, Byron left Cambridge -- presumably riding his bear into the sunset and no doubt leaving a big steaming pile of bear shit in the headmaster's office.


text:
Pre-order now. Dispatches in 15-20 days*. Conditions Apply*
This product dispatches in 8-10 business days*. Conditions Apply*
Order today with Bajaao Express , and your product will dispatch in 24 hours
Special Import. Usually dispatches in 15-18 Days. Conditions Apply*
Special import. Dispatches in 5-8 days from International Warehouse. Conditions Apply*
Neutrik NF2D-5 RCA Jack Connector D-Series Green/Nickel
This panel mount RCA connector adheres to Neutrik's industry-standard D-style and can be front or back-mounted. It is equipped with green isolation washers for easy identification.
Neutrik NF2D-5 RCA Jack Features :
Neutrik NF2D-5 RCA Jack Specifications :
Collections: Chassis Panel Mount, Everything Under ₹999, Mega Discount, Neutrik, Power Connectors Adapters, Professional Audio/Video
Sign up for access to exclusive deals, special offers and more …
© 2016 BAJAAO.COM. BAJAO | BAJAAO Music Private Limited


text:
Top Definition
The state of being completely baffled/lost/confused/clueless.
Similar to the saying 'no idea,' except with far less knowledge!
Similar to the saying 'no idea,' except with far less knowledge!
"Bill where are we????"
"No-I-fucking-dear Betty!"
"No-I-fucking-dear Betty!"
by Dave Ex July 29, 2008
The Urban Dictionary Mug
One side has the word, one side has the definition. Microwave and dishwasher safe. Lotsa space for your liquids.Buy the mug
The Urban Dictionary T-Shirt
Smooth, soft, slim fit American Apparel shirt. Custom printed. 100% fine jersey cotton, except for heather grey (90% cotton).Buy the t-shirt
Trending Now
Can you define these popular missing words?


text:
XC60 Personal Offers
The Volvo XC60 available at 0% APR Representative over 25 months, with £1,500 deposit contribution and 3 years complementary servicing when financed on Personal Contract Purchase with Volvo Car Credit*
*Finance subject to status. Ts & Cs apply. 18s or over. Guarantee may be required. Volvo Car Credit RH1 1SR.
The Volvo XC60 D4 SE Nav at £299 a month on Personal Contract Hire with Volvo Car Leasing**. Initial rental £3588, 36 month contract, 10,000 miles per annum, excess mileage charges apply.
**Click above for important information.
The Volvo XC60 with 5 years servicing for £500***
***Click above for important information.
Volvo XC60 Personal Contract Purchase Offer
*Finance subject to status. Ts & Cs apply. 18s or over. Guarantee/Indemnity may be required. Volvo Car Credit RH1 1SR.
XC60 Personal Contract Purchase Offers
D4 FWD SE Nav
Representative example
D4 FWD R-Design Nav
D4 AWD R-Design Nav
24 Monthly payments £299 £319 £329 Customer deposit £6,499 £6,999 £7,499 Finance Deposit Contribution £1,500 £1,500 £1,500 APR 0% APR Representative 0% APR 0% APR On the road price £33,560 £34,835 £36,365 Dealer Contribution £2,410 £2,480 £2,470 Revised on the road price
(less dealer contribution)
£31,150 £32,355 £33,895 Amount of credit £23,151 £23,856 £24,896 Interest charges £0 £0 £0 Total amount payable £31,150 £32,355 £33,895 Optional Final Payment £15,975 £16,200 £17,000 Duration of agreement (months) 25 25 25 Fixed rate of interest p.a. 0% 0% 0% Mileage per annum 10,000 10,000 10,000 Excess mileage charge 14.9p per mile 14.9p per mile 14.9p per mile*Finance subject to status. Retail sales only. 0% only available over 24 months with minimum 20% deposit. Subject to availability at participating dealers only on vehicles registered by 31st December 2016. At the end of the agreement there are 3 options: (i) Renew: Part exchange the vehicle. (ii) Retain: Pay the Optional Final Payment to own the vehicle or (iii) Return the vehicle. Further charges may be made subject to the condition or mileage of the vehicle. Terms and conditions apply. Applicants must be 18 or over. Guarantee/Indemnity may be required. Volvo Car Credit RH1 1SR. The complementary servicing offer is only available when purchasing on Volvo Advantage Personal Contract Purchase at participating dealers, on vehicles ordered between 01/10/2016 to 31/12/2016. Services must be carried out at a Volvo Authorised Repairer. Retail offer only. Excludes fleet operators and business users.
Volvo XC60 Servicing Offer
Also available, 3 years complementary servicing when financing a Volvo at 6.9% APR* representative on Personal Contract Purchase with Volvo Car Credit.
*Finance subject to status. Ts & Cs apply. 18s or over. Guarantee/Indemnity may be required. Volvo Car Credit RH1 1SR.
Terms and Conditions
***Important Information: The service offer is only applicable to eligible Volvo XC90 / XC60 / S60 / V60 / V40 / V40CC (excluding S60 and V60 Business Editions, V60 Plug-in Hybrid and V60 Polestar) vehicles ordered in the customer's name on or after 1st October 2016 up to and including 31st December 2016.
The services must be carried out in the United Kingdom at a Volvo Authorised Repairer by Volvo Approved Technicians at the correct competence level.
5 year offer: The retail service is for 5 years or 62.5k miles (D2 engines), 90K miles (all other engines), whichever occurs first and includes 5 services at a cost to the customer of £500 incl. VAT (£416.67 ex VAT).
3 year offer: The retail service is for 3 years or 37.5k miles (D2 engines), 54K miles (all other engines), whichever occurs first and includes 3 services at a cost to the customer of £300 incl. VAT (£250 ex VAT).
The retail offer is only available for purchase at any time up to 1 month after car registration, and as long as the vehicle meets the appropriate conditions.
Services must be carried out in line with manufacturers service schedules as per VIDA (copies of which are available on request), which may be updated from time to time according to manufacturer's instructions. Services should be undertaken in line with the time and mileage intervals specified in the Volvo Service Handbook supplied with the car.
The service offer includes parts and labour for all scheduled services. Owners are responsible for topping up the various fluids and coolant in between services. Wear and tear items such as brake pads, discs, bulbs, wiper blades, tyres and brake fluid are not included.
The service offer is not available on vehicles that have undergone any form of aftermarket unapproved tuning or performance enhancement and excludes all non-scheduled service work and accident damage.
The service offer is transferable to subsequent owners of the car but not transferable to another car. No refund is available if the services are not used. Volvo reserves the right to amend or withdraw this offer at any time.
Subject to additional terms and conditions, and excludes fleet operators. Retail Offer only.
Volvo XC60 Personal Contract Hire Offer
The Volvo XC60 D4 SE Nav at £299 a month on Personal Contract Hire with Volvo Car Leasing**. Initial rental £3588, 36 month contract, 10,000 miles per annum, excess mileage charges apply.
All as standard:
Cruise Control Dynamic Chassis City Safety DSTC (Dynamic Stability and Traction Control) Active TFT Crystal Driver's Information Display Bluetooth DAB Radio 17" Valder Alloy Wheels Leather-faced Upholstery Sensus Connect with High Performance Sound**Important Information: 18's & over, subject to status. You will not own the vehicle and it must be returned in good condition to avoid further charges. Excess mileage charges 17.28p per mile. Subject to availability at participating dealers for vehicles registered 01/10/16 to 31/12/16. Not available with other promotions. Provided by Lex Autolease Ltd trading as Volvo Car Leasing, SK3 0RB.


text:
July 3, 2006
Some countries already monitor text messages
According to the Contra Costa Times "several repressive governments are reading along, texting back and even editing messages -- with the help of North American companies".
... "The article claims self-censorship of cell phones and text messaging -- is not new to North American companies and implies that predictive text technologies plays a role.
"Some (manufacturers selling phones) into particularly restrictive regions with censorship regulations have asked for a secondary scrubbing of the language databases to make sure all profanity is removed," AOL spokeswoman Erin Gifford. said.
"A major customer of ours asked for the language database to be rechecked, likely to be in compliance with Russian regulations."
In an earlier article, The ContraCosta Times reports that in China, forbididen words include "Taiwan" or any statements regarding democracy.
The Chinese government can slow down the text message system to filter and spot what it considers subversive messaging, said Julien Pain of the press freedom group Reporters Without Borders.
The People's Republic of China started screening text messages in 2004 after word of the SARS outbreak spread via cell phone in spite of little local media coverage."
The Permanent Link to this page is: https://textually.org/textually/archives/2006/07/012822.htm


text:
Though I literally have been back in NYC for less than 15 hours, I'll be on the road again in less than 24 for a much needed vacation. Leaving the office always gives me a bit of anxiety (which is something I am constantly trying to work on), so I'm doing the best I can today to make sure my teams feel secure before I leave the office. That means today will be a buckle-down day, and I've already sucked it up that an early release for Summer Fridays just isn't in the cards for me.
Aside from completing all your assignments before leaving the office, it's important to send one final email with a list of items that your teams need to be aware of in your absence – the "While-I'm-Out" email. In its best form, this is an appreciated courtesy. In its worst, this note can seem like a to-do list for your colleagues to complete while you're frolicking on the beach. Whether you're gone for a day, a week or a month, here are a few things to keep in mind while drafting the "While-I'm-Out:"
Step one, finish your work – This note is NOT the opportunity to pass along your projects to other team members. Complete your work before you leave. If you don't think you can get to something, stay late. If you can't stay late, enlist help to finish the project before you go. If you were assigned something, you should finish it
Think about ALL your responsibilities – Do you monitorNew York Timesin the morning for the team? Make sure another person gets the paper each morning. Do you have the dial-in for the weekly call with the client? Make sure your manager has the passcode. It's the little things that we forget to take care of before we go that can be the most annoying to figure out in our absence
Speak up and be heard – Make sure your team is aware of what you're putting in your email. Do not send a "While-I'm-Out" without discussing moving projects with your team first. If you have questions, send your note to your supervisor for a quick look before it goes to the team. If she has concerns, she can tell you then instead of calling you while you're boogie boarding
image via


text:
Welcome to Hunt's Taylor Creek Contractors, Inc.
where we have your dreams nailed!!
We are a Full -Service General Contracting Company. We are experts in Commercial Buildings including church meetinghouses and public facilities, as well as Custom Homes. When you combine our company values of Integrity and Honesty with our High-Level of Quality Work and Experience, there is no doubt our clients will be a returning customer and completely satisfied!


text:
March 2009
Winter Sunshine
Justin Time Records
Though it's a fool's gambit to credit any living jazz vocalist as the world's greatest, it would be imprudent not to acknowledge that the indefatigable Sheila Jordan, going stronger than ever at 80, must rank within the top two or three. Winter Sunshine, Jordan's 21st album, was recorded live in Montreal last February, a few months prior to her 80th birthday. To suggest it is exemplary Jordan is, again, foolhardy—ever since 1962's landmark Portrait of Sheila, her recordings have remained unfailingly brilliant. There is no good or bad Jordan. There is just Jordan (which is rather like saying there is just Mount Everest).
Perhaps, though, her live recordings do offer a slight advantage. First, there is the delectably playful banter she volleys with the skill and precision of Roger Federer. Also, there is the magical way in which she peppers the proceedings with stories from her rich professional past (culminating with the warmly, winningly autobiographical "Sheila's Blues"). Finally, there are her loving nods to her musical heroes, here including her own "Ballad for Miles," Davis' "Little Willie Leaps" and, perhaps most splendidly, a meandering "Lady Be Good" dedicated, dazzling scat and all, to Ella Fitzgerald.


text:
Root 3000+ Android through Root Master [Download]
Rooting is the highest desire of Android user these days and coming because it gives total control to user right away. Rooting helps not only using root accessed apps but also remove unwanted apps from the phone to improve the memory. Purchasing an Android for oneself is getting a customized system. If root is not done properly then you may brick the device.
However, different mobile phone has different principle to get rooted or use different softwares to root. But with Root master software user can root more than 3000+ android device under one roof. This Root master tool will successfully root your device by following the tool instruction. As the tool supports Root engine, multi-platform and comes with authorized management system. This only roots and uninstalls the junk items from your phone.
You might be wondering why rooting is important or what is the risk involved in it then check out our article facts to know about android and its related terms & their use [Part- I]. The Root master tool now updated with version 1.7.0 that brings the rooting support of Android 4.3 devices. With the tool you can able to root Samsung, Huawei, Lenovo, Hisense, ZTE, Sony, Tianyu, Cool, Motorola etc models. The rooting will be in just minimum time and it will definitely optimize the phone.
ROOT Master V1.7.0 update:
- Added support for Android 4.3 a key root
- Improved some models Spreadtrum success rate
- Improve Huawei Y320-T00, Y500-T00 models such success rate
- Improve the system and part of a large number of Android 4.x Android 2.3 systems the success rate
- Optimize root process and shorten the time-consuming root of most models
You just have to download the ROOT MASTER Tool from below given link and follow the instruction. Do like our Facebook and Google+ page to get more updates on tweaks and easy android softwares to help you out in daily life. If you want to know how to manage android devices from computer easily then there is software that we have given link to download.
Related Posts